LARA YOUNG: Open Payments
NPI 1023358751 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,839 in 120 payments from 14 companies in 2025. Trend: 2023 $1,620 · 2024 $1,686 · 2025 $1,839
Food & beverage: $1,839
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $276 |
| Lundbeck LLC | 17 | $268 |
| Alkermes, Inc. | 16 | $250 |
| Janssen Pharmaceuticals, Inc | 11 | $219 |
| Otsuka America Pharmaceutical, Inc. | 16 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $200 |
| Teva Pharmaceuticals USA, Inc. | 13 | $163 |
| Vanda Pharmaceuticals Inc. | 4 | $91 |
| Neurocrine BioSciences, Inc. | 3 | $52 |
| ABBVIE INC. | 2 | $46 |
Products named: COBENFY, ABILIFY MAINTENA, ARISTADA, INVEGA SUSTENNA, CAPLYTA, ABILIFY ASIMTUFII, FANAPT, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
